X0306 4 2018-12-22 0 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001458753 Ross Leonard S C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 0 1 0 0 See Remarks Common Stock 2018-12-22 4 M 0 62892 A 94709 D Common Stock 2018-12-22 4 F 0 18522 1.65 D 76187 D Restricted stock units 2018-12-22 4 M 0 62892 0.00 D Common Stock 62892 0 D Restricted stock units convert into common stock on a one-for-one basis. No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. Reflects the last reported sale price for the Registrant's shares of common stock on the Nasdaq Global Market on December 21, 2018. On December 22, 2017, the reporting person was granted 62,892 restricted stock units, vesting in full on the first anniversary of the grant date. Vice President of Finance and Chief Accounting Officer /s/ John Mercer, Attorney-in-Fact 2018-12-26